SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-20-000287
Filing Date
2020-01-10
Accepted
2020-01-10 16:36:58
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 ndra_s3.htm S-3 895644
2 OPINION ON LEGALITY ndra_ex51.htm EX-5.1 20414
3 CONSENTS OF EXPERTS AND COUNSEL ndra_ex231.htm EX-23.1 4259
4 IMAGE ndra_ex51000.jpg GRAPHIC 2358
5 IMAGE ndra_s3000.jpg GRAPHIC 7335
6 IMAGE ndra_s3001.jpg GRAPHIC 17717
7 IMAGE ndra_s3002.jpg GRAPHIC 31054
8 IMAGE ndra_s3003.jpg GRAPHIC 7564
  Complete submission text file 0001654954-20-000287.txt   1013029
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-235883 | Film No.: 20521510
SIC: 3845 Electromedical & Electrotherapeutic Apparatus